MELD-based allocation scheme for liver transplantation in Israel

Israel Medical Association Journal

Volumn 8, Issue 9, 2006, Pages 651-652

  Onaca, Nicholas ^a,b   Mor, Eytan ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Child Turcotte Pugh score; Liver transplantation; Model of End Stage Liver Disease score; Organ allocation

Indexed keywords

BILIRUBIN; CREATININE; SODIUM;

BACTERIAL PERITONITIS; DISEASE SEVERITY; EDITORIAL; ESOPHAGUS VARICES BLEEDING; FOLLOW UP; HEALTH CARE SYSTEM; HEPATORENAL SYNDROME; HOSPITAL ADMISSION; HUMAN; INTERNATIONAL NORMALIZED RATIO; ISRAEL; LIFE EXPECTANCY; LIVER FAILURE; LIVER TRANSPLANTATION; MORTALITY; ORGAN DONOR; PATIENT CARE; PATIENT SELECTION; PREDICTION; PROGNOSIS; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; RESOURCE ALLOCATION; RISK ASSESSMENT; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SURVIVAL; VALIDATION PROCESS;

FORECASTING; HUMANS; ISRAEL; LIVER FAILURE; LIVER TRANSPLANTATION; MODELS, STATISTICAL; PATIENT SELECTION; RESOURCE ALLOCATION; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TISSUE AND ORGAN PROCUREMENT; WAITING LISTS;

EID: 33749060203     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (14)

1. http://www.unos.org/data/ - The OPTN database.
2. Eghtesad B, Bronsther O, Irish W, et al. Disease gravity and urgency of need as guidelines for liver allocation. Hepatology 1994;20(1 Pt 2):56-62S.
3. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33(2):464-70.
4. Velidedeoglu E, Mange KC, Frank A, et al. Factors differentially correlated with the outcome of liver transplantation in HCV+ and HCV-recipients. Transplantation 2004;77(12):183442.
5. Oton-Nieto E, Barcena-Marugan R, Carrera-Alonso E, et al. Variability of MELD score during the year before liver transplantation. Transplant Proc 2005;37(9):3887-8.
6. Said A, Williams J, Holden J, et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 2004;40(6):897-903.
7. Freeman RB Jr, Wiesner RH, Roberts JP, McDiarmid S, Dykstra DM, Merion RM. Improving liver allocation: MELD and PELD. Am J Transplant 2004;4(Suppl 9:114-31.
8. Dunn W, Jamil LH, Brown LS, et al. MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology 2005;41(2):353-8.
9. Habib S, Berk B, Chang CC, et al. MELD and prediction of post-liver transplantation survival. Liver Transpl 2006;12(3):440-7.
10. Ben-Haim M, Carmiel M, Katz P, Shabtai E, Oren R. Nakache R. Is the model of end-stage liver disease (MELD) valid in Israel? A critical analysis of live transplant waiting list mortality. IMAJ 2006;8:605-9.
11. Cholongitas E, Marelli L, Shusang V, et al. A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation. Liver Transpl 2006;12(7):1049-61.
12. Ruf AE, Kremers WK, Chavez LL, Descalzi VI, Podesta LG, Villamil FG. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl 2005;11(3):336-43.
13. Huo TI, Lin HC, Wu JC, et al. Limitation of the model for end-stage liver disease for outcome prediction in patients with cirrhosis-related complications. Clin Transplant 2006;20(2):188-94.
14. Huo TI, Lin HC, Wu JC, et al. Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis. Liver Transpl 2006;12(1):65-71.